UCB in ‘dynamic mode’ as work begins at new biologics research centre
July 31, 2009Research and Development UCB, biologics
UCB has opened its new biologics research centre in the UK, marking an investment of £25 million for the growing …
Crestor drives positive results for AZ
July 31, 2009Sales and Marketing AZ, Crestor
AstraZeneca delivered a solid second quarter performance thanks to US delays to generic rivals and strong Crestor sales. The results …
Reshuffle at the top as Mylan deals with quality queries
July 31, 2009Manufacturing and Production, Research and Development Mylan
US pharmaceutical firm Mylan has promoted chief operating officer Heather Bresch to the post of president as it rides a …
Merck Serono asks EMEA to re-think Erbitux rejection
July 30, 2009Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono
Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …
Sanofi makes bold promises with Q2 results
July 30, 2009Sales and Marketing Sanofi-Aventis, patents
Sanofi-Aventis has promised its 2013 sales will at least match those the company made last year, despite facing huge and …
Skills council for pharma
July 30, 2009Business Services, Manufacturing and Production training
The UK pharmaceutical sector is set to get its own body dedicated to identifying and addressing key skills issues. A …
Synexus expands
July 30, 2009Research and Development CRO, Synexus
CRO Synexus has doubled its head office capacity as it continues to grow across the UK, Central and Eastern Europe, …
DeHavilland launches political monitoring service for pharma
July 30, 2009Medical Communications DeHavilland
A new online monitoring service will provide pharmaceutical decision-makers with briefings on opportunities and threats to their businesses coming from …
BMS profits surge ahead
July 30, 2009Sales and Marketing BMS
Bristol Myers-Squibb's earnings growth massively outstripped its income in the second quarter of the year. The company saw its net …
Engaging with doctors online
July 29, 2009Medical Communications, Sales and Marketing doctors, online communities
Digital marketing in all its forms can no longer be regarded the preserve of the 'early adopters' or young people …
Roche strengthened by swine flu
July 29, 2009Sales and Marketing Roche
The effect of the swine flu pandemic has boosted Roche's half-year results, adding to figures already strengthened by the company's …
NHS faces ‘bleak’ funding prospects
July 29, 2009NHS, healthcare
The prospects for future funding of the NHS "now look bleak", according to a new report by the King's Fund …
Genzyme cuts forecasts on production problems
July 29, 2009Manufacturing and Production, Sales and Marketing Genzyme
The contamination problems at Genzyme's Allston Landing production plants have caused the firm to scale back its revenue forecasts for …
WorldEvents opens office in Switzerland
July 28, 2009Business Services WorldEvents
Event management agency WorldEvents has opened a new office in Switzerland. It has recruited Uwe Bornemann, an experienced event professional, …
Merck and Schering-Plough propose shareholder settlement
July 28, 2009Sales and Marketing MA, Merck
Merck and Schering-Plough's legal battles with their shareholders may be approaching a truce. Two class action lawsuits earlier this year …
GSK to co-market Amgen’s osteoporosis drug in Europe
July 28, 2009Sales and Marketing Amgen, Deals, GSK
GlaxoSmithKline has signed a major deal with Amgen to co-market its new osteoporosis treatment denosumab in Europe, Australia, New Zealand …
Contract research news in brief
July 28, 2009Research and Development CRO
The first crop of second-quarter figures from the contract research sector reveals a mixed bag, with PPD and Icon affected …
Canada’s biotech challenge
July 27, 2009Research and Development Canada, Transition Therapeutics, biotech, funding
The Niagara Falls are one of the wonders of the natural world, and every year millions of visitors from around …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
